Common Contracts

Underwriting Agreement

Underwriting Agreement • May 24th, 2011 • CVD Equipment Corp • Special industry machinery, nec • New York

• Contract Type
  Underwriting Agreement
• Filed
  May 24th, 2011
• Company
  CVD Equipment Corp
• Industry
  Special industry machinery, nec
• Jurisdiction
  New York

Introductory. CVD Equipment Corporation, a New York corporation (the “Company”), proposes to issue and sell (the “Offering”) to ThinkEquity LLC (the “Underwriter”) an aggregate of 841,695 shares (the “Underwritten Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). The Company also proposes to issue and sell at the Underwriter’s option, solely to cover over-allotments, an aggregate of up to 126,255 additional shares of Common Stock (the “Option Securities,” and, together with the Underwritten Securities, the “Securities”) as set forth below.

par value, $0.01 per share) Underwriting Agreement

Underwriting Agreement • February 2nd, 2011 • LGL Group Inc • Electronic components, nec • New York

• Contract Type
  Underwriting Agreement
• Filed
  February 2nd, 2011
• Company
  LGL Group Inc
• Industry
  Electronic components, nec
• Jurisdiction
  New York

Introductory. The LGL Group, Inc., a Delaware corporation (the “Company”), proposes to issue and sell (the “Offering”) to ThinkEquity LLC (the “Underwriter”) an aggregate of 304,348 shares (the “Underwritten Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). The Company also proposes to issue and sell at the Underwriter’s option, solely to cover over-allotments, an aggregate of up to 45,652 additional shares of Common Stock (the “Option Securities,” and, together with the Underwritten Securities, the “Securities”) as set forth below.

Common Stock ($0.001 par value) Underwriting Agreement

Underwriting Agreement • October 5th, 2010 • Oragenics Inc • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  October 5th, 2010
• Company
  Oragenics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Introductory. Oragenics, Inc., a Florida corporation (the “Company”), proposes to issue and sell (the “Offering”) to the several underwriters named in Schedule I (the “Underwriters”), for whom ThinkEquity LLC is acting as representative (the “Representative”), an aggregate of _________ shares (the “Underwritten Securities”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”). The Company also proposes to issue and sell at the Underwriters’ option, solely to cover over-allotments, an aggregate of up to _________ additional shares of Common Stock (the “Option Securities”, and together with the Underwritten Securities, the “Securities”) as set forth below.

Common Stock (no par value) Underwriting Agreement

Underwriting Agreement • October 7th, 2009 • AspenBio Pharma, Inc. • In vitro & in vivo diagnostic substances • New York

• Contract Type
  Underwriting Agreement
• Filed
  October 7th, 2009
• Company
  AspenBio Pharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

Introductory. AspenBio Pharma, Inc., a Colorado corporation (the “Company”), proposes to issue and sell (the “Offering”) to ThinkEquity LLC (the “Underwriter”) an aggregate of 4,482,609 shares (the “Underwritten Securities”) of the Company’s common stock, no par value per share (the “Common Stock”). The Company also proposes to issue and sell at the Underwriter’s option, solely to cover over-allotments, an aggregate of up to 672,391 additional shares of Common Stock (the “Option Securities”, and together with the Underwritten Securities, the “Securities”) as set forth below.